Compare NUVB & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | VERX |
|---|---|---|
| Founded | 2018 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2020 | 2020 |
| Metric | NUVB | VERX |
|---|---|---|
| Price | $6.96 | $13.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | $11.38 | ★ $24.25 |
| AVG Volume (30 Days) | ★ 5.8M | 2.4M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $62,902,000.00 | ★ $748,444,000.00 |
| Revenue This Year | $203.82 | $12.78 |
| Revenue Next Year | $58.18 | $11.61 |
| P/E Ratio | ★ N/A | $302.25 |
| Revenue Growth | ★ 698.96 | 12.25 |
| 52 Week Low | $2.87 | $10.21 |
| 52 Week High | $9.75 | $26.54 |
| Indicator | NUVB | VERX |
|---|---|---|
| Relative Strength Index (RSI) | 58.20 | 56.27 |
| Support Level | $5.28 | $12.16 |
| Resistance Level | $8.95 | $13.56 |
| Average True Range (ATR) | 0.37 | 0.52 |
| MACD | 0.02 | 0.12 |
| Stochastic Oscillator | 62.35 | 83.86 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.